Effects of tacrolimus on ischemia‐reperfusion injury

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Liver transplantation

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/JLTS.2003.50020PMID 12548502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of FK506 on Warm Ischemia and reperfusion Injury in the Rat Liver

  2005cited by this paper
• Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction

  2005cited by this paper
• Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation

  2003cited by this paper
• Platelet adhesion mediated by fibrinogen–intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo1

  2002cited by this paper
• Washing out of lipophilic compounds induces a transient increase in the passive Ca(2+) leak in permeabilized A7r5 cells.

  2002cited by this paper
• FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK5061

  2002cited by this paper
• Tacrolimus: a review of its use for the management of dermatoses

  2002cited by this paper
• Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.

  2002cited by this paper
• Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus.

  2002cited by this paper
• Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation

  2002cited by this paper
• A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

  2002cited by this paper
• Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.

  2002cited by this paper
• Liver and kidney preservation by perfusion.

  2002cited by this paper
• Inhibition of the initial wave of NF‐κB activity in rat muscle reduces ischemia/reperfusion injury

  2001cited by this paper
• Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney.

  2001cited by this paper
• FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes.

  2001cited by this paper
• Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

  2001cited by this paper
• Transcending conventional therapies: the role of biologic and other novel therapies.

  2001cited by this paper
• Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer

  2001cited by this paper
• Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts.

  2000cited by this paper
• Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.

  2000cited by this paper
• Caspases

  1999cited by this paper
• Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes.

  1999cited by this paper
• The mitochondrial permeability transition and the calcium, oxygen and pH paradoxes: one paradox after another.

  1999cited by this paper
• Long-term results of pancreas transplantation under tacrolius immunosuppression.

  1999cited by this paper
• The mitochondrial permeability transition mediates both necrotic and apoptotic death of hepatocytes exposed to Br-A23187.

  1999cited by this paper
• Mitochondrial transport of cations: channels, exchangers, and permeability transition.

  1999cited by this paper
• Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine.

  1999cited by this paper
• On the mechanism of the failure of mitochondrial function in isolated guinea-pig myocytes subjected to a Ca2+ overload.

  1999cited by this paper
• Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.

  1999cited by this paper
• V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis.

  1999cited by this paper
• Tacrolimus vs Neoral in renal and renal/pancreas transplantation

  1999cited by this paper
• Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis.

  1999cited by this paper
• Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain.

  1998cited by this paper
• Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury.

  1998cited by this paper
• Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation

  1998cited by this paper
• A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

  1998cited by this paper
• Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: The pH paradox and cytoprotection by glucose, acidotic pH, and glycine

  1998cited by this paper
• LONG-TERM RESULTS OF PANCREAS TRANSPLANTATION UNDER TACROLIMUS IMMUNOSUPPRESSION

  1998cited by this paper
• Do immunosuppressants directly affect neutrophils, resulting in protection of the liver against ischemia-reperfusion injury?

  1998cited by this paper
• Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

  1997cited by this paper
• The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.

  1997cited by this paper
• Caspases: Intracellular Minireview Signaling by Proteolysis

  1997cited by this paper
• Tumor Necrosis Factor α-Induced E-selectin Expression Is Activated by the Nuclear Factor-κB and c-JUN N-terminal Kinase/p38 Mitogen-activated Protein Kinase Pathways*

  1997cited by this paper
• Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia.

  1997cited by this paper
• Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group.

  1997cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat

  1996cited by this paper
• FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver.

  1996cited by this paper
• Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury.

  1996cited by this paper
• FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation.

  1996cited by this paper
• Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.

  1996cited by this paper
• E-selectin involvement in the pathogenesis of splanchnic artery occlusion shock.

  1995cited by this paper
• Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.

  1995cited by this paper
• Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation.

  1995cited by this paper
• Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts.

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers

  1995cited by this paper
• Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

  1995cited by this paper
• Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

  1995cited by this paper
• The biochemistry of programmed cell death

  1995cited by this paper
• Protective effect of heat shock pretreatment with heat shock protein induction before hepatic warm ischemic injury caused by Pringle's maneuver.

  1995cited by this paper
• The selecting: vascular adhesion molecules

  1995cited by this paper
• Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

  1995cited by this paper
• NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation

  1994cited by this paper
• Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.

  1994cited by this paper
• Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors

  1994cited by this paper
• The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization.

  1994cited by this paper
• Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.

  1994cited by this paper
• E-selectin in the pathogenesis of experimental myocardial ischemia-reperfusion injury.

  1994cited by this paper
• Cytokines and Extrahepatic Sequelae of Ischemia‐Reperfusion Injury to the Liver a

  1994cited by this paper
• Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.

  1994cited by this paper
• Nitric oxide- and hydrogen peroxide-mediated gene expression by glucocorticoids and FK506 in histamine paw edema of mice.

  1994cited by this paper
• Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

  1994cited by this paper
• Role of Kupffer cells in neutrophil activation and infiltration following total hepatic ischemia and reperfusion.

  1994cited by this paper
• Role of neutrophils during the first 24 hours after liver ischemia and reperfusion injury.

  1994cited by this paper
• Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: in vivo demonstration for suppression of TNF-a production in response to endotoxemia.

  1994cited by this paper
• Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes

  1994cited by this paper
• The interleukin-8 AP-1 and κB-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization

  1994cited by this paper
• Hypoxia and reperfusion injury to liver.

  1993cited by this paper
• FK 506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion.

  1993cited by this paper
• NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY

  1993cited by this paper
• H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor.

  1993cited by this paper
• Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment.

  1993cited by this paper
• Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin.

  1993cited by this paper
• Hypoxia and reperfusion injury to liver.

  1993cited by this paper
• Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells

  1993cited by this paper
• Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.

  1993cited by this paper
• Protective Effect of FK506 on Ischemia/Reperfusion‐Induced Myocardial Damage in Canine Heart

  1993cited by this paper
• THE SALUTARY EFFECT OF FK506 IN ISCHEMIA‐REPERFUSION INJURY OF THE CANINE LIVER

  1992cited by this paper
• Inflammation and platelet‐activating factor production during hepatic ischemia/reperfusion

  1992cited by this paper
• Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin.

  1992cited by this paper
• Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

  1992cited by this paper
• Kidney preservation ex vivo for transplantation.

  1992cited by this paper
• Preclinical and clinical study of FK506 in uveitis.

  1992cited by this paper
• Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies.

  1992cited by this paper
• Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex.

  1992cited by this paper
• A PROTECTIVE EFFECT OF FK506 IN ISCHEMICALLY INJURED RAT LIVERS

  1991cited by this paper
• FK 506: historical perspectives.

  1991cited by this paper

• A novel strategy for spinal cord reconstruction via vascularized allogeneic spinal cord transplantation combine spinal cord fusion

  2024cites this paper
• Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial

  2024cites this paper
• Calcineurin Inhibition in Deceased Organ Donors: A Systematic Review and Meta-analysis of Preclinical Studies

  2023cites this paper
• A Potential Route to Reduce Ischemia/Reperfusion Injury in Organ Preservation

  2022cites this paper
• Calcineurin Inhibitors in Lung Donors to Attenuate Ischemia–Reperfusion Injury in Recipients: Next Steps?

  2022cites this paper
• CpG‐ODN‐mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NFκB inhibitory protein IκBβ to drive IL1α and IL1β expression

  2020cites this paper
• CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NF j B inhibitory protein I j B b to drive IL1 a and IL1 b expression

  2020cites this paper
• Pre-treatment with FK506 reduces hepatic ischemia-reperfusion injury in rats.

  2019cites this paper
• Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers

  2016cites this paper
• PROBLEMAS DURANTE EL PERÍODO PERIOPERATORIO DEL TRASPLANTE HEPÁTICO: PROFILAXIS Y TRATAMIENTO

  2016cites this paper
• Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol – Differences or Similarities?

  2015influential citation
• The protective effects of tacrolimus on rat uteri exposed to ischemia-reperfusion injury: a biochemical and histopathologic evaluation.

  2014cites this paper
• Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction

  2014cites this paper
• Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice.

  2013cites this paper
• Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model.

  2013cites this paper
• Crosstalk of inflammatory mediators and lipid parameters as early markers of renal dysfunction in stable renal transplant recipients with regard to immunosuppression.

  2013cites this paper
• Extending Donor Pool with Donation after Cardiac Death in Kidney and Liver Transplantation:What is the Price to Pay?

  2012cites this paper
• Tacrolimus preconditioning of rat liver allografts impacts glutathione homeostasis and early reperfusion injury.

  2012cites this paper
• Donation after cardio-circulatory death liver transplantation.

  2012cites this paper
• Carbon monoxide inhibits apoptosis during cold storage and protects kidney grafts donated after cardiac death

  2011cites this paper
• Tacrolimus modulates liver and pancreas nitric oxide synthetase and heme-oxygenase isoforms and cytokine production after endotoxemia.

  2011cites this paper
• Time Course of Reendothelialization of Stents in a Normal Coronary Swine Model

  2011cites this paper
• Oxidative stress and renal interstitial fibrosis in patients after renal transplantation: current state of knowledge.

  2011cites this paper
• Allograft inflammatory factor-1 is up-regulated in warm and cold ischemia-reperfusion injury in rat liver and may be inhibited by FK506.

  2011cites this paper
• Evaluación de los efectos de una solución de perfusión-lavado con tacrolimus sobre la lesión por isquemia-reperfusión en trasplante hepático

  2011cites this paper
• [Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines].

  2010cites this paper
• Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines

  2010cites this paper
• Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.

  2010cites this paper
• Efecto citoprotector del tacrolimus a dosis bajas sobre islotes de Langeerhans en cultivo sometidos a estímulos por citocinas del rechazo agudo

  2010cites this paper
• Antiapoptotic Effect of Tacrolimus on Cytokine-Challenged Human Islets

  2009cites this paper
• Biochemical and Histological Evaluations of Articular Cartilages Preserved in Cold Storage Solution Containing Green Tea Catechin , EGCG

  2009cites this paper
• Direct vasodilative effect of FK506 on porcine mesenteric artery in small bowel transplantation.

  2009cites this paper
• The neointimal response to stents eluting tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release.

  2008cites this paper
• Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in rat.

  2007cites this paper
• Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats.

  2007cites this paper
• Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function

  2007cites this paper
• Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model.

  2006cites this paper
• In vitro investigations on the differential pro-oxidant and/or antioxidant properties of cyclosporin A and tacrolimus in human and rat liver microsomes.

  2006cites this paper
• Warm ischemia‐reperfusion injury is decreased by tacrolimus in steatotic rat liver

  2006cites this paper
• Calidad del donante y resultado inmediato en el trasplante hepático

  2004cites this paper
• Tacrolimus ameliorates cerebral vasodilatation and intracranial hypertension in the rat with portacaval anastomosis and hyperammonemia

  2004cites this paper
• Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion.

  2004cites this paper
• Tacrolimus ameliorates cerebral vasodilatation and intracranial hypertension in the rat with portacaval anastomosis and hyperammonemia.

  2004cites this paper
• Influence of Antithymoglobulins on Ischemia/Reperfusion Injury in perfused non-human primate tissues

  2004cites this paper
• The immunosuppressant drug FK506 prevents Fas-induced apoptosis in human hepatocytes.

  2004cites this paper